Bisacodyl



Indications and Reactions:

Role Indications Reactions
Primary
Constipation 30.1%
Bowel Preparation 28.8%
Colonoscopy 11.0%
Laxative Supportive Care 9.6%
Clostridial Infection 2.7%
Dyspnoea 2.7%
Hormone Replacement Therapy 2.7%
Product Used For Unknown Indication 2.7%
Cerebrovascular Accident Prophylaxis 1.4%
Hypertension 1.4%
Major Depression 1.4%
Oedema Peripheral 1.4%
Pain 1.4%
Type 2 Diabetes Mellitus 1.4%
Vomiting 1.4%
Colitis Ischaemic 14.7%
Nausea 8.8%
Small Intestinal Obstruction 8.8%
Vomiting 8.8%
Mallory-weiss Syndrome 5.9%
Oesophagitis 5.9%
Superior Mesenteric Artery Syndrome 5.9%
Weight Decreased 5.9%
Acute Myocardial Infarction 2.9%
Blood Urine Present 2.9%
Completed Suicide 2.9%
Dehydration 2.9%
Dermatitis Allergic 2.9%
Drug Dispensing Error 2.9%
Drug Ineffective 2.9%
Drug Toxicity 2.9%
Dysgeusia 2.9%
Faecaloma 2.9%
Gait Disturbance 2.9%
Gastrointestinal Haemorrhage 2.9%
Secondary
Product Used For Unknown Indication 20.5%
Constipation 17.6%
Pharyngitis 7.9%
Hypertension 7.1%
Insomnia 6.2%
Upper Respiratory Tract Inflammation 5.7%
Colonoscopy 4.3%
Depression 3.6%
Pyrexia 3.6%
Urinary Tract Infection 2.6%
Back Pain 2.4%
Pain 2.4%
Type 2 Diabetes Mellitus 2.4%
Benign Prostatic Hyperplasia 2.1%
Dyspepsia 2.1%
Atrial Fibrillation 1.9%
Bowel Preparation 1.9%
Diabetes Mellitus 1.9%
Drug Use For Unknown Indication 1.9%
Oedema Peripheral 1.9%
Colitis Ischaemic 10.9%
Diarrhoea 10.9%
Drug Interaction 9.4%
Vomiting 6.3%
Constipation 4.7%
Drug Abuse 4.7%
Eosinophilia 4.7%
Hyperthermia 4.7%
Lactic Acidosis 4.7%
Pancreatitis 4.7%
Shock 4.7%
Toxicity To Various Agents 4.7%
Abdominal Pain 3.1%
Brain Oedema 3.1%
Catheter Site Infection 3.1%
Hypokalaemia 3.1%
Hyponatraemia 3.1%
Liver Disorder 3.1%
Multiple Drug Overdose Intentional 3.1%
Nephrolithiasis 3.1%
Concomitant
Product Used For Unknown Indication 36.2%
Drug Use For Unknown Indication 29.9%
Constipation 6.3%
Pain 5.2%
Prophylaxis 3.1%
Hypertension 2.4%
Multiple Myeloma 2.2%
Depression 1.6%
Adverse Event 1.6%
Nausea 1.5%
Diabetes Mellitus 1.4%
Insomnia 1.3%
Gastrooesophageal Reflux Disease 1.2%
Anxiety 1.1%
Osteoporosis 0.9%
Acute Lymphocytic Leukaemia 0.9%
Breast Cancer 0.8%
Non-small Cell Lung Cancer 0.8%
Metastases To Bone 0.8%
Prostate Cancer 0.8%
Vomiting 18.2%
Death 9.4%
Weight Decreased 8.4%
Thrombocytopenia 5.0%
Weight Increased 5.0%
Pulmonary Embolism 4.8%
Pain 4.6%
Pneumonia 4.4%
Urinary Tract Infection 4.0%
Pyrexia 3.8%
Urosepsis 3.8%
Renal Failure Acute 3.6%
Sepsis 3.6%
Unresponsive To Stimuli 3.6%
International Normalised Ratio Increased 3.4%
Febrile Neutropenia 3.1%
Respiratory Failure 3.1%
Tremor 2.9%
Cerebrovascular Accident 2.7%
Deep Vein Thrombosis 2.5%
Interacting
Back Disorder 8.6%
Back Pain 8.6%
Bladder Obstruction 8.6%
Depression 8.6%
Fibromyalgia 8.6%
Hypertension 8.6%
Irritable Bowel Syndrome 8.6%
Vitamin D Deficiency 8.6%
Blood Cholesterol Increased 5.7%
Blood Pressure High 5.7%
Gastrooesophageal Reflux Disease 5.7%
Hypersensitivity 5.7%
Acid Reflux (Esophageal) 2.9%
Allergy 2.9%
High Cholesterol 2.9%
Drug Interaction 66.7%
Drug Administration Error 33.3%